Melodie Young

1.9k total citations
41 papers, 1.3k citations indexed

About

Melodie Young is a scholar working on Immunology, Dermatology and Hematology. According to data from OpenAlex, Melodie Young has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 16 papers in Dermatology and 7 papers in Hematology. Recurrent topics in Melodie Young's work include Psoriasis: Treatment and Pathogenesis (30 papers), Dermatology and Skin Diseases (15 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Melodie Young is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (30 papers), Dermatology and Skin Diseases (15 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Melodie Young collaborates with scholars based in United States, United Kingdom and Canada. Melodie Young's co-authors include Neil J. Korman, Mark Lebwohl, Abby S. Van Voorhees, Alan Menter, Sylvia Hsu, Bruce F. Bebo, Elizabeth J. Horn, Laura F. Morris, James Tomfohrde and Peter Šťastný and has published in prestigious journals such as Science, Journal of the American Academy of Dermatology and Dermatologic Clinics.

In The Last Decade

Melodie Young

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melodie Young United States 15 1.0k 575 245 223 141 41 1.3k
Marta Ferrán Spain 24 922 0.9× 634 1.1× 178 0.7× 264 1.2× 171 1.2× 79 1.4k
Pablo Coto‐Segura Spain 18 656 0.6× 427 0.7× 144 0.6× 235 1.1× 136 1.0× 60 1.1k
Siew Eng Choon Malaysia 20 1.1k 1.0× 718 1.2× 319 1.3× 233 1.0× 312 2.2× 52 1.5k
Angelo Ruggiero Italy 27 1.0k 1.0× 893 1.6× 266 1.1× 158 0.7× 263 1.9× 101 1.6k
Marco Galluzzo Italy 22 1.0k 1.0× 720 1.3× 207 0.8× 212 1.0× 305 2.2× 86 1.4k
Luca Potestio Italy 25 778 0.7× 839 1.5× 220 0.9× 142 0.6× 207 1.5× 114 1.4k
Marianne Notter Switzerland 5 1.3k 1.2× 732 1.3× 250 1.0× 342 1.5× 266 1.9× 9 1.6k
Dagmar Wilsmann‐Theis Germany 19 739 0.7× 677 1.2× 169 0.7× 155 0.7× 203 1.4× 68 1.1k
Tiffani K. Hamilton United States 14 829 0.8× 505 0.9× 221 0.9× 165 0.7× 129 0.9× 25 1.2k
Isabelle Hampele United States 6 1.3k 1.3× 751 1.3× 261 1.1× 344 1.5× 256 1.8× 8 1.6k

Countries citing papers authored by Melodie Young

Since Specialization
Citations

This map shows the geographic impact of Melodie Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melodie Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melodie Young more than expected).

Fields of papers citing papers by Melodie Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melodie Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melodie Young. The network helps show where Melodie Young may publish in the future.

Co-authorship network of co-authors of Melodie Young

This figure shows the co-authorship network connecting the top 25 collaborators of Melodie Young. A scholar is included among the top collaborators of Melodie Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melodie Young. Melodie Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cather, Jennifer Clay, Melodie Young, Shehla Admani, et al.. (2025). Genital Psoriasis: Shining Light on This Hidden Disease. JEADV Clinical Practice. 4(4). 719–731.
2.
Gold, Linda Stein, et al.. (2025). Management of Challenging Psoriasis Clinical Scenarios. Dermatology and Therapy. 15(6). 1555–1567.
3.
4.
Cather, Jennifer Clay, et al.. (2022). A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up. Dermatology and Therapy. 12(9). 2013–2038. 8 indexed citations
5.
Young, Melodie, et al.. (2017). Psoriasis for the primary care practitioner. Journal of the American Association of Nurse Practitioners. 29(3). 157–178. 15 indexed citations
6.
Young, Melodie, et al.. (2016). Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who are Candidates for Biologic Therapy. Journal of the Dermatology Nurses’ Association. 10(2). 120–132. 8 indexed citations
7.
Young, Melodie. (2014). Onychomycosis. Journal of the Dermatology Nurses’ Association. 6(5). 239–243. 1 indexed citations
8.
Strober, Bruce, Jennifer Clay Cather, David Cohen, et al.. (2012). A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2. Dermatology and Therapy. 2(1). 2–2. 10 indexed citations
9.
Strober, Bruce, Jennifer Clay Cather, David Cohen, et al.. (2012). A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1. Dermatology and Therapy. 2(1). 1–1. 24 indexed citations
10.
Bremmer, Samuel, Abby S. Van Voorhees, Sylvia Hsu, et al.. (2010). Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 63(6). 1058–1069. 95 indexed citations
11.
Rosenbach, Misha, Sylvia Hsu, Neil J. Korman, et al.. (2009). Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 62(4). 655–662. 115 indexed citations
12.
Voorhees, Abby S. Van, Mark Lebwohl, Neil J. Korman, et al.. (2009). Treatment of severe scalp psoriasis: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 60(6). 962–971. 79 indexed citations
13.
Strober, Bruce, Emily Berger, Jennifer Clay Cather, et al.. (2009). A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach. Journal of the American Academy of Dermatology. 61(1). S1–S46. 24 indexed citations
14.
Doherty, Sean D., Abby Van Voorhees, Mark Lebwohl, et al.. (2008). National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. Journal of the American Academy of Dermatology. 59(2). 209–217. 117 indexed citations
15.
Kalb, Robert E., Jerry Bagel, Neil J. Korman, et al.. (2008). Treatment of intertriginous psoriasis: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 60(1). 120–124. 54 indexed citations
16.
Lebwohl, Mark, Jerry Bagel, Joel M. Gelfand, et al.. (2007). From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis. Journal of the American Academy of Dermatology. 58(1). 94–105. 84 indexed citations
17.
Pariser, David M., Jerry Bagel, Joel M. Gelfand, et al.. (2007). National Psoriasis Foundation Clinical Consensus on Disease Severity. Archives of Dermatology. 143(2). 239–42. 110 indexed citations
18.
Young, Melodie, et al.. (2004). Practical considerations in future psoriasis therapies. Dermatologic Clinics. 22(4). 487–492. 3 indexed citations
19.
Young, Melodie, et al.. (2003). Integrating biologic therapies into a dermatology practice: practical and economic considerations. Journal of the American Academy of Dermatology. 49(2). 139–142. 5 indexed citations
20.
Young, Melodie. (2002). PHOTOTHERAPY TREATMENT PROTOCOLS. Journal of the Dermatology Nurses’ Association. 204. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026